Circassia Pharmaceuticals ( (GB:NIOX) ) has provided an announcement.
NIOX Group Plc has received a revised proposal from Keensight Capital for a potential cash offer to acquire the company at 81 pence per share. The board is considering the offer and has allowed Keensight to conduct due diligence, though discussions are still in the preliminary stages. The company is also exploring other potential offers to maximize shareholder value.
More about Circassia Pharmaceuticals
NIOX Group Plc is a medical device company specializing in the point of care diagnosis, monitoring, and management of asthma.
YTD Price Performance: -3.49%
Average Trading Volume: 641,108
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £244.8M
See more data about NIOX stock on TipRanks’ Stock Analysis page.